Correlation Between Astellas Pharma and Bayer AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and Bayer AG, you can compare the effects of market volatilities on Astellas Pharma and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Bayer AG.

Diversification Opportunities for Astellas Pharma and Bayer AG

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Astellas and Bayer is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Bayer AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Bayer AG go up and down completely randomly.

Pair Corralation between Astellas Pharma and Bayer AG

Assuming the 90 days horizon Astellas Pharma is expected to generate 1.49 times more return on investment than Bayer AG. However, Astellas Pharma is 1.49 times more volatile than Bayer AG. It trades about 0.01 of its potential returns per unit of risk. Bayer AG is currently generating about -0.08 per unit of risk. If you would invest  1,107  in Astellas Pharma on September 16, 2024 and sell it today you would lose (57.00) from holding Astellas Pharma or give up 5.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.32%
ValuesDaily Returns

Astellas Pharma  vs.  Bayer AG

 Performance 
       Timeline  
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Bayer AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bayer AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Astellas Pharma and Bayer AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astellas Pharma and Bayer AG

The main advantage of trading using opposite Astellas Pharma and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.
The idea behind Astellas Pharma and Bayer AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope